New strategy of reprogramming regulatory T cells may improve cancer therapies

Posted by on May 15, 2019 5:17 pm
Categories: health

Therapies that harness the power of the immune system against cancer have made remarkable progress against certain tumors but still remain ineffective in most cancer patients. A new study describes a method of reprogramming regulatory T cells that usually suppress immune responses into inflammatory cells that not only permit but also intensify an antitumor immune response.

Leave a Reply

Your email address will not be published.